Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Palvella Therapeutics, Inc. (PVLA) had Weighted-Average Shares Outstanding (Diluted) of 11.05M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-9.47M |
|
-- |
|
-- |
|
$9.25M |
|
$-9.25M |
|
$-0.22M |
|
$-9.47M |
|
$-9.47M |
|
$-9.47M |
|
$-9.47M |
|
$-9.47M |
|
$-9.47M |
|
$-9.25M |
|
$-9.25M |
|
11.05M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
11.05M |
$-0.86 |
|
$-0.86 |
|
| Balance Sheet Financials | |
$73.75M |
|
-- |
|
-- |
|
$73.75M |
|
$9.62M |
|
-- |
|
$16.35M |
|
$25.97M |
|
$47.78M |
|
$47.78M |
|
$47.78M |
|
11.06M |
|
| Cash Flow Statement Financials | |
$-12.20M |
|
-- |
|
$-0.85M |
|
$83.60M |
|
$70.43M |
|
$-13.17M |
|
$2.53M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.67 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-12.20M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-19.82% |
|
-19.82% |
|
-12.84% |
|
-19.82% |
|
$4.32 |
|
$-1.10 |
|
$-1.10 |
|